Nipah Virus
Top in ID: Experts seek rapid tests for deadly viruses; doxy-PEP shows potential for STIs
The Coalition for Epidemic Preparedness Innovation, or CEPI, is spending $14.9 million to develop rapid tests for Nipah virus and Lassa fever.
Scientists pursue on-the-spot rapid tests for Nipah virus, Lassa fever
The Coalition for Epidemic Preparedness, or CEPI, is funding a project to develop on-the-spot rapid tests for Nipah virus and Lassa fever to better monitor outbreaks of both diseases, the organization announced.
Nipah virus: Going from bat to worse
Nipah virus (NiV), an RNA virus, and Nipah virus infection (NiVI) are relatively recently discovered entities. NiVI is a particularly lethal infection, with a mortality rate usually higher than 50%. Its reservoir is the flying fruit bat, but it can infect a wide range of mammals, including humans. NiV has been cited as a potential agent of bioterrorism because of many suitable physical attributes of the virus and the high mortality caused by the infection in people. Although there is no evidence of any country or group attempting to weaponize NiV, the potential certainly exists.